From: Targeting p53 by small molecules in hematological malignancies
Hematological malignancy | Small molecule | Potential target |
---|---|---|
Leukemia | ||
ALL | Nutlin | MDM232-34 |
RITA | p5382 | |
JNJ-26854165 | p53, E2F199 | |
AML | *Nutlin | MDM235,38,42,43,46 |
MI-219 | MDM248 | |
RITA | p538 | |
*PRIMA-1 | p538,82,88,93 | |
JNJ-26854165 | p53, E2F199 | |
CLL | Nutlin | MDM254-56,58-60 |
RITA | p538 | |
PRIMA-1 | p538,92 | |
CML | Nutlin | MDM261,62 |
MI-219 | MDM261 | |
Lymphoma | ||
HL | Nutlin | MDM267,68 |
MCL | Nutlin | MDM269-72 |
Birkitt’s lymphoma | Nutlin | MDM276 |
B Cell lymphoma | MI-219 | MDM274 |
Follicular lymphoma | MI-319 | MDM278 |
Myeloma | Nutlin | MDM263-65 |
RITA | p5384, JNK87 | |
PRIMA-1Met | p53, p7394 | |
MIRA-1 | p5396 | |
Halofuginone | p5397 |